Back
Entrada Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
TRDA
Entrada Therapeutics, Inc.
Last Price:
$11.83
Seasonality Move:
-22.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
Entrada Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.73 | Sell |
| 20-day SMA: | 11.26 | Buy |
| 50-day SMA: | 10.95 | Buy |
| 200-day SMA: | 8 | Buy |
| 8-day EMA: | 10.6 | Buy |
| 20-day EMA: | 6.97 | Buy |
| 50-day EMA: | 3.53 | Buy |
| 200-day EMA: | 1 | Buy |
Entrada Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.31 | Buy |
| Relative Strength Index (14 RSI): | 54.57 | Buy |
| Chaikin Money Flow: | 54079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.7 - 11.82) | Buy |
| Bollinger Bands (100): | (7.65 - 11.49) | Buy |
Entrada Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics, Inc. Stock
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 11.68 while TRDA 8-day simple moving average is 11.73, which is a Sell signal.
-
The stock price of TRDA is 11.68 while Entrada Therapeutics, Inc. 20-day SMA is 11.26, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day simple moving average is 10.95 while TRDA share price is 11.68, making it a Buy technically.
-
TRDA stock price is 11.68 and Entrada Therapeutics, Inc. 200-day simple moving average is 8.00, creating a Buy signal.
TRDA Technical Analysis vs Fundamental Analysis
Sell
44
Entrada Therapeutics, Inc. (TRDA)
is a Sell
Is Entrada Therapeutics, Inc. a Buy or a Sell?
-
Entrada Therapeutics, Inc. stock is rated a SellThe current Entrada Therapeutics, Inc. [TRDA] share price is $11.68. The Score for TRDA is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Entrada Therapeutics, Inc. Stock Info
Market Cap:
446.4M
Price in USD:
11.68
Share Volume:
284.8K
Entrada Therapeutics, Inc. 52-Week Range
52-Week High:
12.93
52-Week Low:
4.93
Sell
44
Entrada Therapeutics, Inc. (TRDA)
is a Sell
Entrada Therapeutics, Inc. Share Price Forecast
-
What is the Entrada Therapeutics, Inc. stock price today?The Entrada Therapeutics, Inc. stock price is 11.68 USD today.
-
Will TRDA stock go up or go down?Entrada Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Entrada Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics, Inc. is overvalued.
Is Entrada Therapeutics, Inc. Stock a Buy?
-
Entrada Therapeutics, Inc. share price is 11.68 while TRDA 8-day exponential moving average is 10.60, which is a Buy signal.
-
The stock price of TRDA is 11.68 while Entrada Therapeutics, Inc. 20-day EMA is 6.97, which makes it a Buy.
-
Entrada Therapeutics, Inc. 50-day exponential moving average is 3.53 while TRDA share price is 11.68, making it a Buy technically.
-
TRDA stock price is 11.68 and Entrada Therapeutics, Inc. 200-day simple moving average is 1.00, creating a Buy signal.
Fundamental Analysis of Entrada Therapeutics, Inc.
Is Entrada Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.26 per share, a decrease this year of $0.19 per share, and an increase next year of $0.23 per share.
Technical Analysis of Entrada Therapeutics, Inc.
Should I short Entrada Therapeutics, Inc. stock?
-
TRDA Moving Average Covergence Divergence (MACD) indicator is 3.31, suggesting Entrada Therapeutics, Inc. is a Buy
-
Entrada Therapeutics, Inc. Relative Strength Index (RSI) is 54.57, which suggest Entrada Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Entrada Therapeutics, Inc. is (10.7 - 11.82), which suggest Entrada Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Entrada Therapeutics, Inc. is (7.65 - 11.49), which suggest Entrada Therapeutics, Inc. is a Buy
* Entrada Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.